Moneeb Khalaph, Philipp Sommer, Philipp Lucas, Denise Guckel, Thomas Fink, Vanessa Sciacca, Mustapha El Hamriti, Guram Imnadze, Martin Braun, Christian Sohns, Leonard Bergau
{"title":"First clinical experience using a visualized sheath for atrial fibrillation ablation.","authors":"Moneeb Khalaph, Philipp Sommer, Philipp Lucas, Denise Guckel, Thomas Fink, Vanessa Sciacca, Mustapha El Hamriti, Guram Imnadze, Martin Braun, Christian Sohns, Leonard Bergau","doi":"10.1111/pace.14555","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Recently, a novel steerable sheath allowing its real-time visualization within a 3D-mapping system was introduced to facilitate atrial fibrillation (AF) ablation.</p><p><strong>Aim: </strong>This study aimed to assess safety and efficacy of AF ablation using the visualized sheath and to compare its performance with a matched control group of patients who received ablation with conventional and non-visualized sheaths.</p><p><strong>Methods: </strong>The study included consecutive patients between 09/2019 and 02/2021 who underwent routine AF ablation using the visualized sheath. Patients were regularly followed-up in our outpatient's clinic. Arrhythmia recurrence was defined as any atrial fibrillation (AF)/ atrial tachycardia (AT) episode lasting > 30 s after a blanking period of 3 months.</p><p><strong>Results: </strong>A total number of 100 patients undergoing ablation using the visualized sheath were compared to a group of 99 matched patients. No major complications were observed. Total procedure duration (108 ± 22 min vs. 112 ± 12 min; p = 0.045), fluoroscopy time (7 ± 3 min vs. 10 ± 5 min; p < 0.001) and -dose (507 ± 501 cGy*cm<sup>2</sup> vs. 783 ± 433 cGy*cm<sup>2</sup> ; p < 0.001) were significantly lower using the visualized sheath. The benefit in terms of procedure duration was mainly driven by a shortened left atrial dwell time (73 ± 13 min vs. 79 ± 12 min; p = 0.001). During a mean follow-up of 12 months, the overall procedural success was 85% in the visualized sheath group versus 83% in the control group (p = 0.948).</p><p><strong>Conclusion: </strong>AF ablation using the novel visualized sheath is safe and effective and leads to a measurable decrease of procedure duration and radiation exposure. The integration of the novel sheath might help to further improve safety and efficacy of AF ablation.</p>","PeriodicalId":520740,"journal":{"name":"Pacing and clinical electrophysiology : PACE","volume":" ","pages":"922-929"},"PeriodicalIF":1.3000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pacing and clinical electrophysiology : PACE","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1111/pace.14555","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Introduction: Recently, a novel steerable sheath allowing its real-time visualization within a 3D-mapping system was introduced to facilitate atrial fibrillation (AF) ablation.
Aim: This study aimed to assess safety and efficacy of AF ablation using the visualized sheath and to compare its performance with a matched control group of patients who received ablation with conventional and non-visualized sheaths.
Methods: The study included consecutive patients between 09/2019 and 02/2021 who underwent routine AF ablation using the visualized sheath. Patients were regularly followed-up in our outpatient's clinic. Arrhythmia recurrence was defined as any atrial fibrillation (AF)/ atrial tachycardia (AT) episode lasting > 30 s after a blanking period of 3 months.
Results: A total number of 100 patients undergoing ablation using the visualized sheath were compared to a group of 99 matched patients. No major complications were observed. Total procedure duration (108 ± 22 min vs. 112 ± 12 min; p = 0.045), fluoroscopy time (7 ± 3 min vs. 10 ± 5 min; p < 0.001) and -dose (507 ± 501 cGy*cm2 vs. 783 ± 433 cGy*cm2 ; p < 0.001) were significantly lower using the visualized sheath. The benefit in terms of procedure duration was mainly driven by a shortened left atrial dwell time (73 ± 13 min vs. 79 ± 12 min; p = 0.001). During a mean follow-up of 12 months, the overall procedural success was 85% in the visualized sheath group versus 83% in the control group (p = 0.948).
Conclusion: AF ablation using the novel visualized sheath is safe and effective and leads to a measurable decrease of procedure duration and radiation exposure. The integration of the novel sheath might help to further improve safety and efficacy of AF ablation.
导读:最近,一种新型的可操纵护套被引入,可以在3d绘图系统中实时可视化,以促进心房颤动(AF)消融。目的:本研究旨在评估使用可视化鞘消融房颤的安全性和有效性,并将其与对照组接受常规和非可视化鞘消融的患者进行比较。方法:该研究纳入了2019年9月至2021年2月期间使用可视化鞘进行常规房颤消融的连续患者。病人在我们的门诊部定期随访。心律失常复发定义为在3个月的空白期后任何房颤(AF)/房性心动过速(AT)发作持续> 30秒。结果:总共有100名患者接受了可视化鞘的消融,与99名匹配的患者进行了比较。无重大并发症。总手术时间(108±22 min vs 112±12 min);P = 0.045),透视时间(7±3 min vs. 10±5 min;p 2 vs. 783±433 cGy*cm2;结论:使用新型可视化鞘消融AF是安全有效的,可显著减少手术时间和辐射暴露。新型鞘的整合可能有助于进一步提高心房颤动消融的安全性和有效性。